AlleyCorp supported Thyme Care with $125M Series E funding announced by Thyme Care.
Public source
Publisher name
Public post
Another major milestone for Thyme Care with the announcement of their $125M Series E funding! For nearly six years, Thyme Care has transformed the experience around canc…
Company
AlleyCorp
AlleyCorp is an early stage venture fund and incubator that founds and funds transformative companies in New York.
- Industry
- Financial Services
- Location
- New York, US
- Company size
- 11–50 employees
About AlleyCorp
AlleyCorp builds and invests in transformative companies for the present and future in New York. We are humbled to partner with brilliant and determined entrepreneurs along the way. Unconstrained by industry, AlleyCorp originates the ideas, hires the early teams, funds, launches, and grows each company, and maintains an integral leadership role from beginning through exit. AlleyCorp companies have collectively raised more than $2B in venture capital and employ thousands of people in New York City and beyond. On the investment side, AlleyCorp is one of the most active early stage funds in New York. Every company we found fuels a stronger foundation for new ideas and entrepreneurs.
See moreLatest activity
Latest activity from AlleyCorp
3 signals
Discover more
Similar signals
Similar public activity from other companies.
Capital & Finance
Thyme Care
Thyme Care announced a Series E funding round of more than $125 million.
Capital & Finance
2CarrotsVC
2CarrotsVC notes that Thyme Care raised $125M+ in a Series E led by Morgan Health, with participation from Humana, CVS Health Ventures, HealthQuest Capital, Frist Cressey Ventures, Foresite Capital, Concord Health Partners, AlleyCorp, and a16z Bio + Health.
Capital & Finance
AlleyWatch
AlleyWatch reported on the latest venture capital, seed, pre-seed, and angel deals for NYC startups for 9/1/2026 featuring funding details for Easy Aerial, Norbert Health, and much more.
Capital & Finance
Concord Health Partners
Concord Health Partners announced that Thyme Care closed a $125 million Series E funding round.
Capital & Finance
MacroHealth